CTi-1

N/A

Report date: 2022/02/08 11:21:08
NME

Base Information

Drug NameCTi-1
Drug Alias NameRNA interference based therapeuticsCTPi-1QP-CO1QP-LI2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsAcute Lung InjuryPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuark Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAcute Lung InjuryPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A